[…]
Read More… from What Every STI Test Developer Should Know About FDA Clinical Trials
What Every STI Test Developer Should Know About FDA Clinical Trials
Category: MDC Blog
ESCMID Global 2025: A Conference Recap on Innovation, Education, and Collaboration
NIH Budget Cuts and Realignment: What Diagnostics and Research Leaders Should Watch
Everything Changes, Yet It’s Still the Same: The LDT Ruling and Its Implications for Laboratories
What the HHS Reorganization Means for Diagnostics and Why Strategic Partnerships Matter Now More Than Ever
The Case for Chromogenic Agar in the Age of MALDI-TOF MS
Risk Management Guidance for Medical Devices Incorporating Machine Learning (ML) or Artificial Intelligence (AI)
From Concept to Market: How the FDA’s Breakthrough Device Designation Works
The Value of Internal Quality Audits
Key Points from the Nov 2024 FDA IVD Roundtable
